Published in Clinical Oncology Week, April 14th, 2003
"Medulloblastomas occurring in children represent a histological spectrum of varying anaplasia and nodularity. In order to determine whether immunohistochemical markers might be useful parameters in subclassifying these tumors, 17 pediatric medulloblastomas, including 9 diffuse/nonanaplastic, 4 diffuse/anaplastic, 3 nodular/nonanaplastic and 1 nodular/anaplastic subtype were studied.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.